Services News Technology Meet Dr. Rose Schedule Now Customer Service Special Offers Location  
 
 
 
 
 
Restorative Services
  Cosmetic Service
  Preventive Services
  Snoring/Sleep Apnea
  One Hour Whitening
  Headaches/TMJ
  Neuromuscular Dentistry
  Cerec Crowns
 
 
 
Join Our E-Mail Newsletter
Click here to Register Today!
 
Headaches/TMJ

The Food and Drug Administration recently approved the use of the NTI Tension Suppression System (NTI-tss) for the prevention and treatment of medically diagnosed migraine and migraine-associated tension-type headache pain. We have had tremendous success with the NTI-tss in our office. The FDA approval of this device is a breakthrough for sufferers.

Our goal is to provide you with useful information about the prevention of headache and migraine headache. We are very excited about the recent Food and Drug Administration (FDA) approval of the NTI-tss and the results of the most recent studies. We recognize that headache and migraine headache can have devastating effects on individuals and families and this device will give many individuals their sought after relief from pain and suffering.

How the NTI-tss works to prevent headache and migraine headache:
Try this simple test: Clench your teeth tightly together. You can actually feel the sides of your face bulge out. That’s the temporalis muscle. Now place a pencil between your front teeth and try to clench again. You notice right away that there is less force on the muscle. That’s how the appliance works to reduce the intensity of clenching. With the NTI-tss device in place, the intense activity of the temporal muscle (which closes and clenches the jaw) is suppressed to less than 1/3 of maximum by preventing any contacting of the back molar teeth. By reducing this neuromuscular activity, migraine pain is reduced or prevented all together, as well as the associated tension-type headaches. Research has shown that teeth clenching is a significant factor in migraine pain. This is where a dentist can really help. The NTI has been shown to be a significant help as a migraine preventative.

More than 23 million people older than 12 years of age suffer severe migraine headaches. The social and economic impact of migraine is staggering, with estimates approaching $17.2 billion per year lost in productivity.

Treatments for migraine headaches typically involve drugs such as Imitrex®. But now there is a promising new treatment recently approved by the FDA that uses no drugs. It’s called the NTI Suppression System (NTI-tss).

In clinical trials, the NTI-tss device considerably reduced or eliminated migraine and associated tension headache pain. It is considered breakthrough technology because there is no risk of side effects compared to pharmaceutical migraine treatments.

Patients who experience migraines typically contract their temporal muscles (which close and clench the jaw) during sleep on average 14 times more intensely than those who do not suffer migraines. Typical sufferers awake nearly every morning with varying degrees of headache pain but have come to accept it as normal and unremarkable.

The NTI-tss device is a small, removable device that snaps onto the front teeth only, which makes it easily tolerated for people who have a gag reflex problem. A dentist custom makes the device in the office, usually in one visit. The patient then wears it while sleeping. There is a daytime device available as well. With the NTI-tss device in place, the intense activity of the temporal muscles is reduced by 2/3 by preventing contact between the back teeth. By reducing this neuromuscular activity, migraine attacks are reduced or prevented altogether, as well as the associated tension-type headaches.

One NTI-tss trial compared the effect of the device to a control device on medically diagnosed migraine sufferers. Each subject had at least 2 migraines per month and was taking physician prescribed Imitrex®.

After just eight weeks of using the NTI-tss:
  • There were no side-effects and no new pain;
  • 82% of NTI-tss users had a 77% average reduction in migraine events;
  • Imitrex® use was reduced by almost 50%
  • Nausea episodes were reduced by 78%
  • Light-sensitive episodes were reduced by 66%
  • Sound-sensitive episodes were reduced by 68%

For a Complimentary Consultation call today!


 

6200 SOM Center Road
Suite B-10 Solon, Ohio 44139
Voice: 440.542.1200  Fax: 440.542.1202
  © Copyright 2006 The Center for Aesthetic and Restorative Dentistry.
Site designed and hosted by Mango Bay Internet. Proud clients of Dr. Rose!